MedTrace Logo

The Study for Evaluate of Safety and Efficacy of Vein of Marshall RF Ablation

NCT05854238 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2025-04-15

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the initial safety and effectiveness of an investigational medical device.

Electrode catheter ablation of the Marshall vein is performed using TIRA, a clinical trial medical device for patients with persistent atrial fibrillation,

Conditions

  • Persistent Atrial Fibrillation

Interventions

DEVICE

TIRA-VoM

treat persistent atrial fibrillation * The ablation temperature range is 50-60℃ * About 2 minutes per ablation

Sponsors & Collaborators

  • Tau-MEDICAL Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Min-Soo Cho, MD, PhD · Asan Medical Center

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-03
Primary Completion
2024-04-04
Completion
2025-04-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05854238 on ClinicalTrials.gov